John P O'Reardon

..The authors assessed the efficacy of sertraline in the treatment of night eating syndrome...

..This case illustrates the importance of careful workup of chest pain in the setting of ECT, even if electrocardiogram findings seem unremarkable initially...

..This case illustrates that neither age nor aortic stenosis by itself precludes ECT in the setting of severe depression. Rather, in each case, a careful weighing of the risks both of proceeding with and withholding ECT is warranted...

..In these subjects, rTMS was, in fact, associated with relief of depressive symptoms and preexisting headache pain. This indicates that rTMS may be beneficial for both disorders in some patients...

..Although further study is needed, these results suggest that propofol may be a very valuable additional agent for the ECT clinician in the management of PIA, which is a common entity in the setting of ECT...

..Responders to rTMS are resistant to the mood perturbing effects of RTD. This suggests that rTMS does not depend on the central availability of serotonin to exert antidepressant effects in major depression...

..Development of the child has been assessed as fully normal in all follow-up visits with the pediatrician out to 18 months...

..We describe long-term maintenance therapy for major depressive disorder with rTMS...

..One clinical trial has reported efficacy with the SSRI sertraline. Other treatments, such as the anticonvulsant topiramate, phototherapy and other SSRIs, may also offer future promise...

..To test the efficacy of sertraline in the treatment of night eating syndrome...

..Indeed, bright light therapy has shown efficacy in reducing night eating in case studies and should be evaluated in controlled clinical trials...

..02). This first clinical trial of CBT for NES shows significant improvements in the core aspects of NES and weight reduction, suggesting the need for a controlled treatment trial...

..To test a novel method of facilitating pharmacotherapy at a distance and assess the effectiveness of sertraline for the treatment of night eating syndrome (NES)...

....

..In conclusion, research on NES supports the validity of the diagnosis and its inclusion in DSM-V...

..Study 3 compared scores from obese bariatric surgery candidates with and without NES and found appropriate discriminant validity of the NEQ. The NEQ appears to be an efficient, valid measure of severity for NES...

..To propose criteria for diagnosis of the night eating syndrome (NES)...

..This study assessed the prevalence of night eating syndrome and its comorbid psychopathology in a psychiatric population...

..Behavioral factors were identified as useful discriminators of NES. Future work should also examine psychological factors in conjunction with those identified here...

..There is substantial evidence that antidepressant medications treat moderate to severe depression effectively, but there is less data on cognitive therapy's effects in this population...

..In this article, we propose that a novel device technology known as repetitive transcranial magnetic stimulation should be systematically studied as a potential treatment option for women with major depressive disorder during pregnancy...

..To describe the outcomes of a consecutive series of depressed patients treated with vagus nerve stimulation (VNS) following US Food and Drug Administration (FDA) approval of this intervention...

..We tested its safety and efficacy in young persons with a diagnosis of attention-deficit/hyperactivity disorder (ADHD)...

..A case study and an open-label trial with SSRIs suggest that they may treat NES effectively. Randomized controlled trials are needed...

..Night eating syndrome (NES) is characterized by evening hyperphagia and frequent awakenings with ingestion of food. It is associated with obesity and depressed mood. Greater understanding of hormonal influences on NES is desirable...

....

..Guidelines regarding the treatment of depression during pregnancy were recently published by the American Psychiatric Association and the American College of Obstetricians and Gynecologists. We provide a commentary on these guidelines...

..Patients and treatment team need to be aware of this possibility, particularly when ECT is conducted on an outpatient basis...

..The clinical management of this challenging presentation is discussed, including both the anesthetic and psychiatric approaches...

..Understanding such complications and their management strategies avoids unnecessary treatment discontinuation due to manageable ECT complications...

..Given the novelty of TMS, we sought to assess whether patient acceptability would be a barrier to enrolling pregnant women in TMS studies...

..Anesthesiologists should be aware of factors influencing the seizure duration and, keeping in mind the coexisting medical conditions of the patient, adjustments should be made to get the best possible outcome...

..We present the results of an open label pilot study examining treatment with transcranial magnetic stimulation (TMS) in pregnant women with MDD...

..Each case needs to be evaluated on its merits. To our knowledge, this case represents the oldest patient in the literature where ECT has been administered safely for such an extended period in the setting of severe aortic stenosis...

..To describe and examine, in a sample of depressed outpatients, the relationship between level of response to a previous SSRI or SNRI antidepressant trial and subsequent response to duloxetine hydrochloride...

..We present three cases of women exposed to lamotrigine during pregnancy and breastfeeding, with follow up of their infants until 15-18 months of development...

..We examined the acute efficacy of TMS in a randomized sham-controlled trial, under open-label conditions, and its durability of benefit...

..In this article, we describe TMS and its neurobiologic basis, as well as the efficacy and safety data of TMS with regard to a range of psychiatric disorders...

..Although transcranial magnetic stimulation (TMS) can be an effective acute antidepressant treatment, few studies systematically examine persistence of benefit...

..TMS is a promising form of neuromodulation therapy that will most likely become a significant part of clinical practice in the future...

..To date, three agents--lithium, lamotrigine, and olanzapine--have been shown to have prophylactic benefits in treating this highly recurrent disorder...